Package of extended-release buprenorphine, which is used to treat opioid use disorder. Credit: Pete Comparoni, University of Kentucky Photo. Package of extended-release buprenorphine, which is used to ...
LEXINGTON, Ky. (Nov. 2, 2023) — A study by a team of researchers across the country, including two from the University of Kentucky, is the first to demonstrate a connection between the characteristics ...
More than 15 years ago, Yale's Gail D'Onofrio started studying the effectiveness of sublingual (under-the-tongue) buprenorphine for treatment of opioid use disorder (OUD) in the emergency department.
Lev Facher covers the U.S. addiction and overdose crisis. Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to ...
Suboxone (buprenorphine/naloxone) is a brand-name prescription drug used to treat dependence on opioid drugs. This is also known as opioid use disorder. As with other medications, Suboxone can ...
Multiple federal policy changes since 2018 have been intended to increase buprenorphine prescribing in response to a persistent treatment gap for opioid use disorder in the US. Anticipated national ...
The U.S. Food and Drug Administration gave the green light for an extended-release subcutaneous injection to treat moderate to severe opioid use disorder (OUD). DrugTestKitUSA highlights the FDA's new ...
Jenny S. Guadamuz, University of California Berkeley, Berkeley, California. Sarah Axeen, University of Southern California, Los Angeles, California. Dima Mazen Qato ([email protected]), University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results